COVID-19 booster vaccine

All News

Moderna begins phase 3 clinical trial of RSV

American drugmaker Moderna said it had begun the Phase three clinical trial of its Respiratory Syncytial Virus (RSV) vaccine. The…

Read More »
Back to top button